The effects of PNPLA3 have been well established in previous research, but we wanted to see if the risk of liver fibrosis is changed by a certain combination of PNPLA3 and TM6SF2 or MBOAT7 genotypes. Here, TM6SF2 is linked to Hepatic fibrosis.